174 related articles for article (PubMed ID: 16344319)
1. High frequency of submicroscopic hemizygous deletion is a major mechanism of loss of expression of PTEN in uveal melanoma.
Abdel-Rahman MH; Yang Y; Zhou XP; Craig EL; Davidorf FH; Eng C
J Clin Oncol; 2006 Jan; 24(2):288-95. PubMed ID: 16344319
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic PTEN silencing in malignant melanomas without PTEN mutation.
Zhou XP; Gimm O; Hampel H; Niemann T; Walker MJ; Eng C
Am J Pathol; 2000 Oct; 157(4):1123-8. PubMed ID: 11021816
[TBL] [Abstract][Full Text] [Related]
3. Analysis of p16 (CDKN2/MTS-1/INK4A) alterations in primary sporadic uveal melanoma.
Merbs SL; Sidransky D
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):779-83. PubMed ID: 10067984
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity of 1p in uveal melanomas with monosomy 3.
Häusler T; Stang A; Anastassiou G; Jöckel KH; Mrzyk S; Horsthemke B; Lohmann DR; Zeschnigk M
Int J Cancer; 2005 Oct; 116(6):909-13. PubMed ID: 15849744
[TBL] [Abstract][Full Text] [Related]
5. Frequency, molecular pathology and potential clinical significance of partial chromosome 3 aberrations in uveal melanoma.
Abdel-Rahman MH; Christopher BN; Faramawi MF; Said-Ahmed K; Cole C; McFaddin A; Ray-Chaudhury A; Heerema N; Davidorf FH
Mod Pathol; 2011 Jul; 24(7):954-62. PubMed ID: 21499235
[TBL] [Abstract][Full Text] [Related]
6. [Research on the mechanisms of PTEN gene inactivation in ovarian cancer].
Lü QJ; Zhao XD; Song JY; Li XH; Ma Y; Meng H; Jiang WG
Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):266-9. PubMed ID: 16181546
[TBL] [Abstract][Full Text] [Related]
7. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.
Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G
Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052
[TBL] [Abstract][Full Text] [Related]
8. Mutations of the KIT gene and loss of heterozygosity of the PTEN region in a primary malignant melanoma arising from a mature cystic teratoma of the ovary.
Tate G; Tajiri T; Suzuki T; Mitsuya T
Cancer Genet Cytogenet; 2009 Apr; 190(1):15-20. PubMed ID: 19264228
[TBL] [Abstract][Full Text] [Related]
9. PTEN inactivation is rare in melanoma tumours but occurs frequently in melanoma cell lines.
Pollock PM; Walker GJ; Glendening JM; Que Noy T; Bloch NC; Fountain JW; Hayward NK
Melanoma Res; 2002 Dec; 12(6):565-75. PubMed ID: 12459646
[TBL] [Abstract][Full Text] [Related]
10. Status of the NF1 tumor suppressor locus in uveal melanoma.
Foster WJ; Fuller CE; Perry A; Harbour JW
Arch Ophthalmol; 2003 Sep; 121(9):1311-5. PubMed ID: 12963615
[TBL] [Abstract][Full Text] [Related]
11. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma.
Aalto Y; Eriksson L; Seregard S; Larsson O; Knuutila S
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):313-7. PubMed ID: 11157859
[TBL] [Abstract][Full Text] [Related]
12. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity of the thyroid hormone receptor B in posterior uveal melanoma.
Sisley K; Curtis D; Rennie IG; Rees RC
Melanoma Res; 1993 Dec; 3(6):457-61. PubMed ID: 7909244
[TBL] [Abstract][Full Text] [Related]
14. Molecular cytogenetic analysis of archival uveal melanoma with known clinical outcome.
Mensink HW; Kiliç E; Vaarwater J; Douben H; Paridaens D; de Klein A
Cancer Genet Cytogenet; 2008 Mar; 181(2):108-11. PubMed ID: 18295662
[TBL] [Abstract][Full Text] [Related]
15. Clinical and cytogenetic analyses in uveal melanoma.
Kilic E; van Gils W; Lodder E; Beverloo HB; van Til ME; Mooy CM; Paridaens D; de Klein A; Luyten GP
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3703-7. PubMed ID: 16936076
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
Edmunds SC; Kelsell DP; Hungerford JL; Cree IA
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501
[TBL] [Abstract][Full Text] [Related]
17. Deletion mapping of chromosome region 9p21-p22 surrounding the CDKN2 locus in melanoma.
Ohta M; Berd D; Shimizu M; Nagai H; Cotticelli M-G ; Mastrangelo M; Shields JA; Shields CL; Croce CM; Huebner K
Int J Cancer; 1996 Mar; 65(6):762-7. PubMed ID: 8631588
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal gains and losses in uveal melanomas detected by comparative genomic hybridization.
Speicher MR; Prescher G; du Manoir S; Jauch A; Horsthemke B; Bornfeld N; Becher R; Cremer T
Cancer Res; 1994 Jul; 54(14):3817-23. PubMed ID: 8033101
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic regulation identifies RASEF as a tumor-suppressor gene in uveal melanoma.
Maat W; Beiboer SH; Jager MJ; Luyten GP; Gruis NA; van der Velden PA
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1291-8. PubMed ID: 18385040
[TBL] [Abstract][Full Text] [Related]
20. Multiple locations on chromosome 3 are the targets of specific deletions in uveal melanoma.
Cross NA; Ganesh A; Parpia M; Murray AK; Rennie IG; Sisley K
Eye (Lond); 2006 Apr; 20(4):476-81. PubMed ID: 15920570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
